ICUI - ICU Medical, Inc. So'nggi Yangiliklar | Finranks

ICUI - ICU Medical, Inc. So'nggi Yangiliklar | Finranks

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ICU Medical, Inc. (NASDAQ: ICUI)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ICU Medical, Inc. (NASDAQ: ICUI)

NEW YORK, March 25, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating ICU Medical, Inc. (NASDAQ: ICUI) on behalf of the company's shareholders. The investigation seeks to determine whether ICU Medical's directors breached their fiduciary duties in connection with recent corporate actions.

ICU Medical to Participate in Upcoming Investor Conferences

ICU Medical to Participate in Upcoming Investor Conferences

SAN CLEMENTE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences:

ICU Medical, Inc. (ICUI) Q4 2025 Earnings Call Transcript

ICU Medical, Inc. (ICUI) Q4 2025 Earnings Call Transcript

ICU Medical, Inc. (ICUI) Q4 2025 Earnings Call Transcript

ICU Medical (ICUI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

ICU Medical (ICUI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for ICU Medical (ICUI) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates

ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates

ICU Medical (ICUI) came out with quarterly earnings of $1.91 per share, beating the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $2.11 per share a year ago.

ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance

ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance

SAN CLEMENTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended December 31, 2025.

ICU Medical Announces Time of Fourth Quarter 2025 Earnings Conference Call

ICU Medical Announces Time of Fourth Quarter 2025 Earnings Conference Call

SAN CLEMENTE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2025 earnings release and conference call.

Videolar

No Data

There is no data to display